Recruiting studies: Shigella

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Diseas
Phase 2 · 1 location(s) · Eveliqure Biotechnologies GmbH · NCT07049159 Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Phase 1 · 1 location(s) · University of Oxford · NCT05959616 InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
Phase 1 · 1 location(s) · Leiden University Medical Center · NCT05961059 First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Yo
Phase 1 · 1 location(s) · Inventprise Inc. · NCT07205926 The Impact of Shigellosis and Recommended Treatment in Children
Phase 2 · 4 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT07433426

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.